Zymeworks Solidifies Leadership Team With Permanent R&D and Business Officer Appointments
Zymeworks names permanent R&D and business development leaders, strengthening governance and strategic execution as it advances its clinical pipeline and asset aggregation strategy.
ZYMEclinical developmentoncology